Table 5.
Sample | SG (mg/dL) | SIN (mUI/mL) |
---|---|---|
HC | 112.70 ± 22.11 | 2.10 ± 1.27 |
DC | 437.50 ± 0.71### | 2.50 ± 1.31 |
DCV | 429.00 ± 2.83 | 1.95 ± 0.07 |
Metformin | 123.90 ± 33.99∗∗∗ | 1.74 ± 0.06 |
Acarbose | 142.30 ± 31.99∗∗∗ | 2.15 ± 0.39 |
CME 150 | 93.25 ± 20.22∗∗∗ | 1.63 ± 0.71 |
CME 75 | 156.00 ± 15.13∗∗∗ | 1.33 ± 0.15 |
CME 35 | 153.00 ± 30.36∗∗∗ | 2.32 ± 1.32 |
FME 150 | 117.50 ± 41.35∗∗∗ | 1.47 ± 0.55 |
FME 75 | 168.80 ± 11.67∗∗∗ | 2.00 ± 0.87 |
FME 35 | 162.00 ± 28.77∗∗∗ | 2.75 ± 0.35 |
(SG) concentration of glucose; (SIN) insulin; HC: healthy control; DC: diabetic control; DCV: diabetic control vehicle; CME 150: crude methanolic extract at a concentration of 150 mg/kg; CME 75: crude methanolic extract at a concentration of 75 mg/kg; CME 35: crude methanolic extract at a concentration of 35 mg/kg; FME 150: fractional methanolic extract at a concentration of 150 mg/kg; FME 75: fractional methanolic extract at a concentration of 75 mg/kg; FME 35: fractional methanolic extract at a concentration of 35 mg/kg. For the corresponding mean ± SD, ###P < 0.001 compared to the healthy control and ∗∗∗P < 0.01 compared to the diabetic control.